agenT-797

First patient dosed with AgenTus’ cell therapy designed to clear COVID-19 virus while reducing inflammation
Biopharma Reporter
Mon, 11/9/20 - 11:09 am
Agenus
cell therapy
agenT-797
COVID-19
clinical trials